METRC VANCO Study: Local Antibiotic Therapy to Reduce Infection after Operative Treatment of Fractures at High Risk of Infection: A Prospective Multicenter Randomized Controlled Trial (FDA IND#119891)
T
Todd McKinley, MD
Primary Investigator
J
Jessica MacLean
Primary Investigator
Not Recruiting
100 years or below
All
Phase
N/A
1 Location
Brief description of study
The purpose of this study is to compare the proportion of deep surgical site infections within 6 months in patients treated with local Vancomycin powder compared to those treated without local Vancomycin powder.
Detailed description of study
The purpose of this study is to compare the proportion of deep surgical site infections within 6 months in patients treated with local Vancomycin powder compared to those treated without local Vancomycin powder.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Fracture
-
Age: 100 years or below
-
Gender: All
Updated on
01 Aug 2024.
Study ID: 1501570062
